Trademark: 97302121
Word
AVARA PHARMACEUTICAL SERVICES
Status
Pending
Status Code
681
Status Date
Thursday, February 15, 2024
Serial Number
97302121
Mark Type
4000
Filing Date
Tuesday, March 8, 2022

Trademark Owner History

Classifications
40 Contract manufacturing in the field of pharmaceutical products
42 Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical products development; Pharmaceutical research and development
The English translation of AVARA in the mark is SPACIOUS.
"PHARMACEUTICAL SERVICES"

Trademark Events
Feb 16, 2024
On Hold - Electronic Record Review Required
Feb 12, 2024
Approved For Pub - Principal Register
Feb 1, 2024
Teas/Email Correspondence Entered
Feb 1, 2024
Correspondence Received In Law Office
Feb 1, 2024
Teas Request For Reconsideration Received
Oct 6, 2023
Application Extension Granted/Receipt Provided
Oct 6, 2023
Application Extension To Response Period - Received
Aug 1, 2023
Notification Of Subsequent Final Emailed
Aug 1, 2023
Subsequent Final Emailed
Aug 1, 2023
Subsequent Final Refusal Written
Jul 7, 2023
Notification Of Final Refusal Emailed
Jul 7, 2023
Final Refusal E-Mailed
Jul 7, 2023
Final Refusal Written
Jun 20, 2023
Teas/Email Correspondence Entered
Jun 20, 2023
Correspondence Received In Law Office
Jun 20, 2023
Teas Response To Office Action Received
Mar 17, 2023
Application Extension Granted/Receipt Provided
Mar 17, 2023
Application Extension To Response Period - Received
Feb 24, 2023
Withdrawal Of Attorney Granted
Feb 24, 2023
Teas Withdrawal Of Attorney Received
Feb 21, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 21, 2023
Teas Change Of Correspondence Received
Feb 21, 2023
Teas Change Of Owner Address Received
Dec 19, 2022
Notification Of Non-Final Action E-Mailed
Dec 19, 2022
Non-Final Action E-Mailed
Dec 19, 2022
Non-Final Action Written
Dec 18, 2022
Assigned To Examiner
Mar 14, 2022
New Application Office Supplied Data Entered
Mar 11, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24